| Autor: |
de Oliveira, Ana Beatrice Magalhães, Luchiari, Beatriz, Bonilha, Isabella, Barreto, Joaquim, Nogueira, Ana Claudia Cavalcante, Ceniccola, Guilherme Duprat, Polanczyk, Carisi Anne, Sposito, Andrei Carvalho, de Carvalho, Luiz Sérgio Fernandes |
| Předmět: |
|
| Zdroj: |
ESC Heart Failure; Apr2023, Vol. 10 Issue 2, p1488-1491, 4p |
| Abstrakt: |
6 Segal R, Lubart E, Leibovitz A, Berkovitch M, Habot B, Yaron M, Caspi D. Early and late effects of low-dose aspirin on renal function in elderly patients. The prevalence of heart failure (HF) worldwide nearly doubled from 33.5 million in 1990 to 64.3 million in 2017.[1] Although the age-standardized prevalence rate of HF has decreased by 20.3% in high-income countries, it remained stable or increased in middle-income countries (MIC) such as countries like India and China. Mujaj et al.[3] reported a cohort-designed primary prevention (PP)-based large-scale study and showed a 26% increase in the risk of incident HF among aspirin users compared to non-users. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text